Navigation Links
Rigel to Present at BIO CEO & Investor Conference
Date:2/6/2008

SOUTH SAN FRANCISCO, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the BIO CEO & Investor Conference 2008 in New York on Monday, February 11 at 11:45 a.m. EST.

To access the live audio webcast or the subsequent archived recording, log on to http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

Contact: Ryan Maynard

Phone: 650.624.1284

Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Rigel Announces Pricing of Public Offering of Common Stock
2. Rigel to Present Research Programs at Scientific Conferences
3. Rigel to Present at BIO Investor Forum 2007
4. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
5. SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
7. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. ViroPharma to Present at the BIO CEO & Investor Conference
9. Perrigo Company to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
11. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  Northwell Health ... the advance of precision cancer research. ... largest health care provider, Northwell Health diagnoses ... Indivumed, GmbH is a Germany ... medical therapies. Together they will greatly expand cancer ...
(Date:1/17/2017)... Belgium (PRWEB) , ... January 17, 2017 , ... ... sample preparation and epigenetics research, recently announced a collaboration with the Heidelberg University ... DNA amplification method for library preparation, following the company’s successful launch of ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... the prestigious Tibbetts Award from the U.S. Small Business Administration. The ... created a significant economic or social impact […] and are considered the best of ...
(Date:1/13/2017)... 13, 2017 Research and Markets has announced the ... offering. ... market to grow at a CAGR of 16.83% during the period 2017-2021. ... prospects of the global biopolymers market for 2017-2021. To calculate the market ... of biopolymer products. The report also includes a a discussion of the ...
Breaking Biology Technology:
(Date:12/16/2016)... YORK , Dec. 16, 2016 The global wearable ... USD 12.14 billion by 2021 from USD 5.31 billion in 2016, ... ... is mainly driven by technological advancements in medical devices, launch of ... rising preference for wireless connectivity among healthcare providers, and increasing focus ...
(Date:12/15/2016)... ... and Markets has announced the addition of the "Global Military Biometrics ... forecasts the global military biometrics market to grow at a CAGR of ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/15/2016)... 14, 2016 "Increase in mobile transactions is ... mobile biometrics market is expected to grow from USD ... 2022, at a CAGR of 29.3% between 2016 and ... the growing demand for smart devices, government initiatives, and ... "Software component is expected to grow at a high ...
Breaking Biology News(10 mins):